Medicus Pharma (MDCX) CSO Edward J. Brennan Receives 688,235-Share Award

What Happened

• Edward J. Brennan, Chief Scientific Officer of Medicus Pharma (MDCX), was granted equity awards on 2026-09-04. The filing shows an acquisition of 588,235 shares at $0.17 per share (total value reported $100,294) and a separate 100,000-share derivative award recorded at $0.00.
• These transactions are awards/compensation (not open-market purchases or sales), so they reflect company-granted equity rather than a personal buy or sale.

Key Details

• Transaction date: 2026-09-04; filing date: 2026-09-08 (filed within required period; not late).
• Awarded: 588,235 shares @ $0.17 (value $100,294) and 100,000 derivative shares @ $0.00 (recorded value $0).
• Shares owned after the transaction: not specified in the Form 4 filing summary provided.
• Footnote: the 100,000-share derivative award is an option granted on Sept 4, 2026 and is scheduled to vest quarterly in four equal installments over one year.
• Transaction code: A (Grant/Award).

Context

• The 588,235-share award is compensation-related; such grants are common for executives and do not by themselves indicate insider buying or selling intent.
• The 100,000-share item is a derivative (option) with a vesting schedule — the filing does not indicate immediate sale or cashless exercise.